Resource library
Our regulatory position papers and whitepapers on digital health technologies in clinical trials. Three download without an account; a free account opens the rest after email confirmation and personal approval, usually within one business day. No sales calls attached.
The Smartphone in Digital Endpoints
Indispensable conduit, immature instrument — the phone’s role in capturing, processing and submitting digital endpoint data
Read the summary →The eCOA / ePRO Vendor’s Hidden Obligations
A companion reading from the vendor’s seat — where your build and release choices place you inside the perimeters
Read the summary →Qualification of Digital Endpoints for Regulatory Decision-Making
Why validation produces the evidence — and qualification is the separate regulatory decision that the evidence is fit for a defined context of use.
Read the summary →Diversity, Representativeness and Equitable Access in DHT Deployment
Why who a device can reach is a data-validity question — and why the durable regulatory anchor is the representativeness of the enrolled population.
Read the summary →Sensor-Based DHTs Cleared by FDA: A Landscape Annex
A structured view of the sensor-based digital health technologies FDA has authorised — what they measure, who makes them, how they connect, and what the list does not tell a sponsor
Sign in to download →Validating Sensor-Derived Endpoints in Clinical Trials
Why a sensor reading is only as good as its verification, analytical, clinical and usability validation — and the interpretation threshold that makes it an endpoint.
Read the summary →A paper raised a question about your study?
The people who wrote these papers run the assessments. Bring the device and the protocol; fifteen minutes is enough to know whether it matters for your trial.
Book a 15-minute call